Countries North America
Merck to Acquire JSR’s Chromatography Business to Strengthen Downstream Bioprocessing Portfolio
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphe...
October 16, 2025 | News
Scanogen Secures FDA Breakthrough Device Designation for Rapid Sepsis Diagnostic in the United States
-Scanogen Inc., a molecular diagnostics company pioneering next-generation technologies for infectious disease detection, announced that the U.S. Food and ...
October 16, 2025 | Regulatory
AstraZeneca Invests $445 Million to Expand Texas Manufacturing Hub in the United States, Doubling Global Lokelma Production
AstraZeneca announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the...
October 16, 2025 | News
LTS Acquires Renaissance Lakewood to Expand Global CDMO Capabilities in Nasal and Sterile Drug Delivery
LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company announces the acquisition of Renaissance Lakewood, LLC ("Renaissance")...
October 14, 2025 | News
Waters Launches Xevo™ CDMS to Redefine Mega-Mass Biomolecule Analysis
Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules. Enables accurate analysis of protein comp...
October 14, 2025 | News
AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines in...
October 10, 2025 | News
Made Scientific and Streamline Bio Validate AI-Driven Robotic Platform for Cell Therapy Manufacturing
Made Scientific, a leading clinical and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, a ...
October 07, 2025 | News
Wasatch BioLabs Expands Long-Read Sequencing Portfolio with Oxford Nanopore Research Assays
Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read se...
October 07, 2025 | News
RoosterBio and Secretome Therapeutics Achieve Commercial-Scale Production Milestone for Lead Cell Therapy STM-01
RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and...
October 07, 2025 | News
AbbVie’s BOTOX® Achieves Primary and Secondary Endpoints in Phase 2 ELATE Trial for Essential Tremor
OnabotulinumtoxinA (BOTOX®) met the primary endpoint in the Phase 2 trial, demonstrating a statistically significant improvement ...
October 07, 2025 | News
Turning Signals into Cures: The Big Data Blueprint for Cell Therapy Factories
Cell therapy manufacturing is entering a data-driven era, as the industry grapples with complex production processes, high costs, and the need for personal...
October 07, 2025 | Analysis
Japan’s Daiichi Sankyo Expands Global R&D Footprint with New Research Institute in San Diego
Daiichi Sankyo (TSE: 4568) has established Daiichi Sankyo Research Institute in San Diego, representing the third research institute established outside of...
October 06, 2025 | News
ExQor Technologies Prepares for Clinical Trials of Regenerative Platform Aiming to Reverse Alzheimer’s Damage
ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine pla...
October 06, 2025 | News
Celltrion Launches AVTOZMA IV FDA Approved Tocilizumab Biosimilar in United States
The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as t...
October 03, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
